ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

What's Up With These Ridiculous Stock Gains?

Steve Reitmeister didn't want me to tell you this. He felt that one strategy's performance stands out so much that... Read on >>

Quote:

Search for Ticker

Free Membership

Search:

RX: Ims Health Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

IMS HEALTH INC (NYSE)
RX	21.46	-0.06	(-0.28%)	Vol. 7,828,675	16:00 ET

IMS Health is the global provider of information solutions to the pharmaceutical and healthcare industries. IMS Health consists of: the IMS segment, which consists of the market information and decision-support services business for the pharmaceutical and healthcare industries conducted by IMS Health and IMS Health Strategic Technologies, Emerging Markets, and a majority ownership interest in Cognizant Technology Solutions Corporation.

General Information

IMS HEALTH INC

901 Main Avenue Norwalk, CT 06851 Phone: 203 845-5200 Fax: 203 845-5299 Web: www.imshealth.com Email: askir@imshealth.com

Industry	BUSINESS INFO SVC
Sector:	Business Services

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/04/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	21.52
52 Week High	21.68
52 Week Low	11.12
Beta	0.96
20 Day Moving Average	8,736,109.00
Target Price Consensus	16.5

% Price Change
4 Week	25.04
12 Week	60.00
YTD	41.95

% Price Change Relative to S&P 500
4 Week	20.27
12 Week	44.43
YTD	17.10

Share Information
Shares Outstanding (millions)	182.39
Market Capitalization (millions)	3,924.97
Short Ratio	2.03
Last Split Date	01/19/1999

Dividend Information
Dividend Yield	0.56%
Annual Dividend	$0.12
Payout Ratio	0.07
Change in Payout Ratio	-0.01
Last Dividend Payout / Amount	11/04/2009 / $0.03

EPS Information
Current Quarter EPS Consensus Estimate	0.40
Current Year EPS Consensus Estimate	1.60
Estimated Long-Term EPS Growth Rate	6.80
Next EPS Report Date	02/04/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.50
30 Days Ago	3.00
60 Days Ago	3.00
90 Days Ago	3.00

Fundamental Ratios

P/E
Current FY Estimate:	13.41
Trailing 12 Months:	12.51
PEG Ratio	1.96

EPS Growth
vs. Previous Year	-6.98%
vs. Previous Quarter	-9.09%

Sales Growth
vs. Previous Year	-5.73%
vs. Previous Quarter:	3.44%

Price Ratios
Price/Book	-
Price/Cash Flow	8.65
Price / Sales	1.81

ROE
09/30/09	-
06/30/09	-
03/31/09	-

ROA
09/30/09	15.17
06/30/09	15.25
03/31/09	14.40

Current Ratio
09/30/09	1.41
06/30/09	1.74
03/31/09	1.79

Quick Ratio
09/30/09	1.41
06/30/09	1.74
03/31/09	1.79

Operating Margin
09/30/09	14.42
06/30/09	14.52
03/31/09	13.77

Net Margin
09/30/09	11.19
06/30/09	17.06
03/31/09	18.65

Pre-Tax Margin
09/30/09	11.19
06/30/09	17.06
03/31/09	18.65

Book Value
09/30/09	-0.23
06/30/09	-0.12
03/31/09	-0.52

Inventory Turnover
09/30/09	-
06/30/09	-
03/31/09	-

Debt-to-Equity
09/30/09	-31.52
06/30/09	-60.52
03/31/09	-13.98

Debt to Capital
09/30/09	-
06/30/09	-
03/31/09	-


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research